Privium Fund Management B.V. Arrowhead Pharmaceuticals, Inc. Transaction History
Privium Fund Management B.V.
- $469 Million
- Q2 2025
A detailed history of Privium Fund Management B.V. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Privium Fund Management B.V. holds 612,214 shares of ARWR stock, worth $21.2 Million. This represents 2.06% of its overall portfolio holdings.
Number of Shares
612,214
Previous 629,214
2.7%
Holding current value
$21.2 Million
Previous $8.02 Million
20.66%
% of portfolio
2.06%
Previous 2.1%
Shares
11 transactions
Others Institutions Holding ARWR
# of Institutions
321Shares Held
99.1MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$543 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$537 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$367 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$220 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$181 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $3.66B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...